Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -21.3 Million AUD | -609.28% |
| 2023 | -3 Million AUD | -1.06% |
| 2022 | -2.97 Million AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 299.22 Thousand AUD | 109.96% |
| 2024 Q4 | -2.95 Million AUD | 0.0% |
| 2024 Q2 | 462.96 Thousand AUD | 108.39% |
| 2024 Q1 | -5.51 Million AUD | -46.3% |
| 2024 Q3 | -4.3 Million AUD | -1030.32% |
| 2023 FY | -3 Million AUD | -1.06% |
| 2023 Q3 | -4.07 Million AUD | 5.98% |
| 2023 Q1 | -2.09 Million AUD | -29.62% |
| 2023 Q4 | -3.77 Million AUD | 7.43% |
| 2023 Q2 | -4.33 Million AUD | -106.58% |
| 2022 Q4 | -1.61 Million AUD | 31.86% |
| 2022 FY | -2.97 Million AUD | 0.0% |
| 2022 Q3 | -2.37 Million AUD | -74.17% |
| 2022 Q2 | -1.36 Million AUD | 0.38% |
| 2022 Q1 | -1.36 Million AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 141.825% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | -2745.221% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 207297.073% |
| Biome Australia Limited | 7.66 Million AUD | 377.824% |
| Patrys Limited | 1.39 Million AUD | 1628.383% |
| Orthocell Limited | 3.68 Million AUD | 677.704% |
| Imugene Limited | -5.83 Million AUD | -264.875% |
| Noxopharm Limited | -534.81 Thousand AUD | -3884.239% |
| PYC Therapeutics Limited | 22.05 Million AUD | 196.595% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 385.872% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 673.978% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | -1797.111% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 1020.183% |
| CSL Limited | 15.28 Billion AUD | 100.139% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -81920.659% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | -6968.574% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 127.284% |
| Starpharma Holdings Limited | 7.65 Million AUD | 378.283% |
| Nanollose Limited | -348.95 Thousand AUD | -6006.326% |
| Memphasys Limited | 1606.00 AUD | 1326883.748% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 1857.727% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -23229.151% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 631.276% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | -225.239% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 1802.507% |
| Race Oncology Limited | 1.38 Million AUD | 1633.054% |
| Nyrada Inc. | -5164.07 AUD | -412523.125% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 106.907% |
| Dimerix Limited | 583.47 Thousand AUD | 3751.92% |
| PharmAust Limited | -1641.00 AUD | -1298385.497% |
| Immutep Limited | 1.44 Million AUD | 1575.732% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 285.181% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 660.007% |
| BTC Health Limited | 16.36 Thousand AUD | 130345.397% |
| Acrux Limited | -1.28 Million AUD | -1559.513% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 110.385% |
| Biotron Limited | -40.49 Thousand AUD | -52515.307% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 14257.202% |
| AdAlta Limited | 1.5 Million AUD | 1513.087% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 4728.212% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 37606.419% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | -5709.707% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -48554.292% |
| Actinogen Medical Limited | 9.93 Million AUD | 314.551% |
| Immuron Limited | 3.33 Million AUD | 738.581% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 920.195% |